查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1859050

贲门失弛症治疗市场报告：趋势、预测与竞争分析（至2031年）

Achalasia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球贲门失弛症治疗市场前景广阔，医院、零售药局和线上药局市场均蕴藏着巨大机会。预计2025年至2031年，全球贲门失弛症治疗市场将以5.1%的复合年增长率成长。推动该市场成长的关键因素包括食道动力障碍盛行率的上升、对非侵入性治疗方案需求的增长以及人们对胃肠道健康的日益重视。

  • Lucintel预测，在预测期内，钙通道阻断剂将是所有药物类别中成长率最高的。
  • 按用途划分，预计医院的成长速度最快。
  • 从区域来看，预计亚太地区在预测期内将达到最高成长。

贲门失弛症治疗市场的新趋势

受持续研究和对更有效、更微创、更个人化治疗方法的需求驱动，贲门失弛症治疗市场正在经历重大变革时期。这些新兴趋势正在重塑临床实践，并改善患有这种慢性食道疾病的患者的治疗效果。

  • 微创内视镜技术：以经口内视镜肌切开术（POEM）为代表的微创内视镜手术正蓬勃发展，技术日趋成熟。这些手术恢復时间更短、併发症更少，且疗效与传统手术相当，因此深受患者和临床医生的青睐。
  • 个人化治疗流程：目前的趋势是基于贲门失弛症亚型（芝加哥分类）和患者个别特征制定个人化治疗流程。这种方法旨在透过客製化介入措施，例如特定的肌切开长度和延伸方案，来优化长期症状缓解和患者个体化的治疗效果。
  • 新型药物：目前，研究人员正在探索除传统钙通道阻断剂和硝酸酯类药物以外的新型药物，例如针对食道发炎和神经再生的生物疗法。这项研究趋势旨在解决贲门失弛症的潜在病理生理机制，并有望在未来提供创伤更小甚至能够改善病情的治疗方法。
  • 先进诊断：将高解析度测压法 (HRM) 与电阻和功能性管腔成像探头 (FLIP) 等先进诊断方式结合，正成为一种新兴趋势。这些精密的工具能够更准确地反映食道动力和下食道括约肌功能，指南治疗方法的选择并更精确地评估手术效果。
  • 长期疗效数据和註册登记：在贲门失弛症的治疗中，收集可靠的长期疗效数据并建立国家和国际註册登记系统变得越来越重要。这一趋势对于比较不同治疗方法的持久性和安全性、为临床指南提供依据以及支持基于实证医学的未来治疗策略决策至关重要。

这些趋势正在显着地重塑贲门失弛症治疗市场，促进创伤更小、更精准的治疗，实现患者个性化护理，推动新型药物疗法的探索，提高诊断准确性，并为长期治疗成功建立更强有力的依证，最终改善患者的生活品质。

贲门失弛症治疗市场的最新趋势

在对更有效、创伤更小、以患者为中心的治疗方法的不断探索的推动下，贲门失弛症治疗市场近期取得了多项重要进展。这些进步正在彻底改变这种棘手的食道动力障碍的治疗方法。

  • POEM的推广：经口内视镜肌切开术（POEM）在全球的推广和完善是一项关键进展。这种微创内视镜治疗方法因其在缓解吞嚥障碍方面优于传统外科肌切开术且恢復更快，正日益受到关注，并被视为一线治疗方案。
  • 机器人辅助Heller肌切开术：近年来，机器人辅助腹腔镜Heller肌切开术的应用日益增多，这是该领域的重要进展。机器人手术能够为外科医生提供更高的精准度、灵活性和更清晰的视野，从而有望改善患者预后并减少手术併发症，尤其是在复杂的贲门失弛症病例中。
  • 增强型气囊扩张术：气囊扩张术的发展主要集中在改善球囊尺寸、充气压力和技术，以优化治疗效果并降低穿孔等併发症的风险。分阶段扩张术越来越普遍，旨在实现渐进且持续的缓解。
  • 诊断准确性提高：诊断工具的进步，特别是结合更新后的芝加哥分类的高解析度测压法（HRM），使得贲门失弛症亚型的分类更加准确。这种诊断准确性的提升可以指南治疗方案的选择，从而为患者提供更具针对性和更有效的干预措施。
  • 联合治疗的出现：越来越多的研究和使用联合治疗方法（例如，肉毒桿菌毒素注射联合气囊扩张或POEM治疗Heller肌切开术后復发），以达到最佳的症状缓解或解决难治性病例，这体现了一种更加个性化的方法。

这些市场趋势共同影响贲门失弛症治疗市场，促进微创但高效的手术，提高手术精确度，改善个人化治疗的诊断分层，并提供灵活的组合策略，从而改善患者的治疗效果，提高贲门失弛症患者的生活品质。

目录

第一章执行摘要

第二章 市场概览

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章 全球贲门失弛症治疗市场（按类型划分）

  • 概述
  • 吸引力分析：按类型
  • 钙拮抗剂：趋势与预测（2019-2031）
  • 硝苯地平：趋势与预测（2019-2031）
  • 肉毒桿菌注射：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031 年）

5. 全球贲门失弛症治疗市场（依应用领域划分）

  • 概述
  • 吸引力分析：依目的
  • 医院：趋势与预测（2019-2031）
  • 零售药局：趋势与预测（2019-2031）
  • 线上药局：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031 年）

第六章 区域分析

  • 概述
  • 全球贲门失弛症治疗市场（按地区划分）

7. 北美贲门失弛症治疗市场

  • 概述
  • 北美贲门失弛症治疗市场按类型划分
  • 北美贲门失弛症治疗市场按应用领域划分
  • 美国贲门失弛症治疗市场
  • 墨西哥贲门失弛症治疗市场
  • 加拿大贲门失弛症治疗市场

8. 欧洲贲门失弛症治疗市场

  • 概述
  • 欧洲贲门失弛症治疗市场按类型划分
  • 欧洲贲门失弛症治疗市场依应用领域划分
  • 德国贲门失弛症治疗市场
  • 法国贲门失弛症治疗市场
  • 西班牙贲门失弛症治疗市场
  • 义大利贲门失弛症治疗市场
  • 英国贲门失弛症治疗市场

9. 亚太地区贲门失弛症治疗市场

  • 概述
  • 亚太地区贲门失弛症治疗市场（按类型划分）
  • 亚太地区贲门失弛症治疗市场依应用领域划分
  • 日本贲门失弛症治疗市场
  • 印度贲门失弛症治疗市场
  • 中国贲门失弛症治疗市场
  • 韩国贲门失弛症治疗市场
  • 印尼贲门失弛症治疗市场

10. 世界其他地区（ROW）贲门失弛症治疗市场

  • 概述
  • ROW贲门失弛症治疗市场按类型划分
  • 按应用领域分類的 ROW 贲门失弛症治疗市场
  • 中东贲门失弛症治疗市场
  • 南美洲贲门失弛症治疗市场
  • 非洲贲门失弛症治疗市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 发展机会：透过申请
  • 全球贲门失弛症治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 企业合併、协议、合作关係和合资企业

第十三章：价值链中主要企业的概况

  • 竞争分析
  • Bausch Health
  • Pfizer
  • Accord HealthCare
  • AdvaCare Pharma
  • Merz Therapeutics
  • Galderma
  • Zydus Pharmaceuticals

第十四章附录

  • 图表清单
  • 表格列表
  • 分析方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global achalasia treatment market looks promising with opportunities in the hospital, retail pharmacy, and online pharmacy markets. The global achalasia treatment market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of esophageal motility disorders, the rising demand for noninvasive treatment options, and the growing awareness about gastrointestinal health.

  • Lucintel forecasts that, within the type category, calcium channel blocker is expected to witness the highest growth over the forecast period.
  • Within the application category, hospital is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Achalasia Treatment Market

The achalasia treatment market is undergoing significant transformation, driven by ongoing research and a desire for more effective, less invasive, and personalized therapeutic approaches. These emerging trends are reshaping clinical practice and improving outcomes for patients suffering from this chronic esophageal disorder.

  • Minimally Invasive Endoscopic Techniques: There's a strong trend towards increasingly refined and novel minimally invasive endoscopic techniques, with Peroral Endoscopic Myotomy (POEM) leading the way. These procedures offer reduced recovery times, fewer complications, and comparable efficacy to traditional surgery, making them highly attractive to both patients and clinicians.
  • Personalized Treatment Algorithms: The trend is shifting towards developing personalized treatment algorithms based on achalasia subtypes (Chicago Classification) and individual patient characteristics. This approach aims to tailor interventions, such as specific myotomy lengths or dilation protocols, for optimal long-term symptom relief and better patient-specific outcomes.
  • Novel Pharmacological Agents: Research is exploring novel pharmacological agents beyond traditional calcium channel blockers and nitrates, including biological therapies targeting esophageal inflammation or nerve regeneration. This trend seeks to address the underlying pathophysiology of achalasia, potentially offering less invasive or even disease-modifying treatments in the future.
  • Advanced Diagnostic Modalities: The integration of advanced diagnostic modalities like high-resolution manometry (HRM) with impedance and functional lumen imaging probe (FLIP) is an emerging trend. These sophisticated tools provide more precise insights into esophageal motility and lower esophageal sphincter function, guiding treatment selection and assessing procedural success with greater accuracy.
  • Long-Term Outcome Data and Registries: There's an increasing emphasis on collecting robust long-term outcome data and establishing national/international registries for achalasia treatments. This trend is crucial for comparing the durability and safety of different interventions, informing clinical guidelines, and supporting evidence-based decision-making for future therapeutic strategies.

These trends are profoundly reshaping the achalasia treatment market by promoting less invasive and more precise interventions, enabling personalized patient care, driving the search for novel drug therapies, enhancing diagnostic accuracy, and establishing a stronger evidence base for long-term treatment success. This ultimately aims for improved patient quality of life.

Recent Developments in the Achalasia Treatment Market

The achalasia treatment market has recently seen several crucial developments, largely driven by a continuous quest for more effective, less invasive, and patient-centric therapeutic options. These advancements are transforming the management of this challenging esophageal motility disorder.

  • Widespread Adoption of POEM: A significant development is the increasing widespread adoption and refinement of Peroral Endoscopic Myotomy (POEM) globally. This minimally invasive endoscopic procedure has become a prominent first-line treatment due to its effectiveness in relieving dysphagia and its faster recovery compared to traditional surgical myotomy.
  • Robot-Assisted Heller Myotomy: Recent advancements include the increased use of robot-assisted laparoscopic Heller myotomy. Robotics offer enhanced precision, dexterity, and visualization for surgeons, potentially leading to improved patient outcomes and reduced operative complications, particularly in complex cases of achalasia.
  • Enhanced Pneumatic Dilation Techniques: Developments in pneumatic dilation focus on refining balloon sizes, inflation pressures, and procedural techniques to optimize outcomes and reduce the risk of complications like perforation. Graded dilations are becoming more common, aiming for gradual and sustained relief.
  • Improved Diagnostic Accuracy: The evolution of diagnostic tools, especially high-resolution manometry (HRM) with Chicago Classification updates, has allowed for more precise subtyping of achalasia. This improved diagnostic accuracy guides treatment selection, leading to more tailored and effective interventions for patients.
  • Emergence of Combination Therapies: There's growing exploration and use of combination therapies, where different treatment modalities (e.g., botulinum toxin injection followed by pneumatic dilation, or POEM for recurrence after Heller myotomy) are employed to achieve optimal symptom relief or manage refractory cases, reflecting a more individualized approach.

These developments are collectively impacting the achalasia treatment market by promoting less invasive yet highly effective procedures, enhancing surgical precision, improving diagnostic stratification for personalized treatment, and offering flexible combination strategies. This leads to better patient outcomes and an improved quality of life for achalasia sufferers.

Strategic Growth Opportunities in the Achalasia Treatment Market

The achalasia treatment market presents significant strategic growth opportunities across key applications, driven by the increasing incidence of the disorder and continuous advancements in therapeutic approaches. Capitalizing on these application-specific demands will be vital for market players to expand their footprint and innovate.

  • Minimally Invasive Procedures Expansion: Expanding the reach and accessibility of minimally invasive endoscopic procedures like POEM is a major growth opportunity. Investing in training programs for gastroenterologists and surgeons, and developing next-generation endoscopic tools, can drive adoption in new regions and healthcare settings.
  • Drug Development for Symptom Management: There is a significant opportunity in developing novel pharmacological agents for long-term symptom management or as bridge therapy, especially for patients unsuitable for invasive procedures. This addresses an unmet need for non-interventional solutions or adjuncts to existing treatments.
  • Diagnostic Tools Enhancement: Growth lies in innovating and disseminating advanced diagnostic tools, particularly next-generation high-resolution manometry systems and functional lumen imaging probes (FLIP). Precise diagnosis is crucial for appropriate treatment selection, and improved tools can differentiate achalasia subtypes, leading to better outcomes.
  • Pediatric Achalasia Treatment: The pediatric segment represents a niche but important growth opportunity. Developing and refining treatment approaches, instruments, and protocols specifically tailored for children with achalasia, considering their unique anatomical and physiological needs, can address a critical unmet clinical demand.
  • Post-Treatment Management and Monitoring: Strategic growth can be found in developing solutions for post-treatment management and long-term monitoring of achalasia patients. This includes digital health solutions for symptom tracking, dietary guidance, and identifying recurrence early, improving patient quality of life and ensuring sustained therapeutic success.

These strategic growth opportunities are profoundly impacting the achalasia treatment market by fostering innovation in less invasive techniques, driving pharmaceutical research, improving diagnostic precision, addressing specific patient demographics, and extending care beyond the initial procedure. This holistic approach promises to enhance patient outcomes and broaden market scope.

Achalasia Treatment Market Driver and Challenges

The achalasia treatment market's trajectory is shaped by various technological, economic, and regulatory factors. Major drivers include the rising global incidence of achalasia and advancements in minimally invasive techniques, while challenges encompass the high cost of advanced procedures, lack of awareness, and the complexity of diagnosis.

The factors responsible for driving the achalasia treatment market include:

1. Rising Incidence of Achalasia: The increasing global prevalence and incidence of achalasia, although a rare disease, contributes significantly to market growth. As more cases are diagnosed, the demand for effective treatment options, ranging from medications to advanced surgical and endoscopic procedures, naturally rises across all regions.

2. Advancements in Minimally Invasive Techniques: The continuous development and widespread adoption of minimally invasive procedures like Peroral Endoscopic Myotomy (POEM) and robot-assisted Heller myotomy are key drivers. These techniques offer improved patient outcomes, shorter recovery times, and reduced morbidity compared to traditional surgery, boosting their market appeal.

3. Improved Diagnostic Technologies: The evolution of diagnostic tools, especially high-resolution manometry (HRM) with detailed Chicago Classification, has enhanced the accuracy and subtyping of achalasia. This leads to earlier and more precise diagnoses, enabling timely intervention and contributing to the overall expansion of the treatment market.

4. Increasing Healthcare Expenditure: Growing healthcare expenditure globally, particularly in emerging economies, contributes to better access to specialized medical facilities and advanced treatment options for achalasia. Increased investment allows for the adoption of newer technologies and procedures, driving market growth.

5. Growing Awareness among Physicians and Patients: Enhanced awareness of achalasia symptoms among primary care physicians and patients leads to earlier referral and diagnosis. This heightened understanding of the condition and its treatment options fosters demand for both diagnostic tools and subsequent therapeutic interventions.

Challenges in the achalasia treatment market are:

1. High Cost of Advanced Procedures: The cost of advanced achalasia treatments, such as POEM and robot-assisted Heller myotomy, can be significantly high. This poses a major challenge, particularly in regions with limited healthcare budgets or inadequate insurance coverage, restricting patient access to optimal care.

2. Lack of Awareness in Underserved Areas: Despite increasing overall awareness, a significant challenge remains in rural and underserved areas where achalasia symptoms may be misdiagnosed or dismissed. This lack of awareness among both patients and local healthcare providers delays diagnosis and appropriate treatment, limiting market penetration.

3. Limited Availability of Skilled Professionals: Advanced procedures like POEM require highly specialized training and expertise, and there is a limited number of gastroenterologists and surgeons proficient in these techniques globally. This scarcity of skilled professionals can restrict the widespread adoption and availability of these treatments.

4. The overall impact of these drivers and challenges on the achalasia treatment market is a dynamic tension between the promise of innovative, less invasive therapies and the hurdles of access, cost, and specialized expertise. While drivers propel market growth by improving outcomes and expanding options, challenges necessitate strategic investments in training, awareness, and cost-effective solutions to ensure equitable access to care.

These drivers and challenges on the achalasia treatment market is a dynamic tension between the promise of innovative, less invasive therapies and the hurdles of access, cost, and specialized expertise. While drivers propel market growth by improving outcomes and expanding options, challenges necessitate strategic investments in training, awareness, and cost-effective solutions to ensure equitable access to care.

List of Achalasia Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies achalasia treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the achalasia treatment companies profiled in this report include-

  • Bausch Health
  • Pfizer
  • Accord HealthCare
  • AdvaCare Pharma
  • Merz Therapeutics
  • Galderma
  • Zydus Pharmaceuticals

Achalasia Treatment Market by Segment

The study includes a forecast for the global achalasia treatment market by type, application, and region.

Achalasia Treatment Market by Type [Value from 2019 to 2031]:

  • Calcium Channel Blockers
  • Nifedipine
  • Botulinum Toxin Injection
  • Others

Achalasia Treatment Market by Application [Value from 2019 to 2031]:

  • Hospitals
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Achalasia Treatment Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Achalasia Treatment Market

The achalasia treatment market is witnessing significant advancements, driven by the increasing prevalence of this rare esophageal motility disorder and a push towards less invasive and more effective therapeutic options. Recent developments focus on refining existing procedures like POEM and Heller myotomy, alongside exploring novel pharmacological and endoscopic interventions. This evolution aims to improve long-term symptom relief and enhance the overall quality of life for patients.

  • United States: The US market leads in adopting advanced endoscopic procedures like Peroral Endoscopic Myotomy (POEM) and robot-assisted Heller myotomy, driven by strong research and development, high healthcare expenditure, and favorable reimbursement policies. There's a focus on achieving long-term symptom control and minimizing complications for achalasia patients.
  • China: China is rapidly expanding its capabilities in achalasia treatment, with increasing adoption of POEM and pneumatic dilation in major hospitals. Growth is propelled by a large patient base, improving healthcare infrastructure, and a growing number of trained endoscopists, making advanced treatments more accessible across the country.
  • Germany: Germany achalasia treatment market emphasizes evidence-based practices and high-quality surgical and endoscopic interventions. There's a strong focus on precise diagnostics using high-resolution manometry and a preference for established procedures like Heller myotomy and pneumatic dilation, with increasing interest in POEM's long-term outcomes.
  • India: India achalasia treatment market is witnessing significant growth, driven by increasing awareness, improving diagnostic capabilities, and the rising availability of endoscopic and surgical expertise. Cost-effectiveness is a key factor, with pneumatic dilation and POEM gaining traction in metropolitan and tier-two cities.
  • Japan: Japan is a pioneer in endoscopic myotomy, particularly POEM, which originated here. The market is characterized by widespread adoption of POEM as a first-line treatment, supported by extensive clinical experience, advanced endoscopic technology, and a focus on minimally invasive procedures for improved patient recovery.

Features of the Global Achalasia Treatment Market

  • Market Size Estimates: Achalasia treatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Achalasia treatment market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Achalasia treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, applications, and regions for the achalasia treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the achalasia treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the achalasia treatment market by type (calcium channel blockers, nifedipine, botulinum toxin injection, and others), application (hospitals, retail pharmacy, online pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Achalasia Treatment Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Calcium Channel Blockers: Trends and Forecast (2019-2031)
  • 4.4 Nifedipine: Trends and Forecast (2019-2031)
  • 4.5 Botulinum Toxin Injection: Trends and Forecast (2019-2031)
  • 4.6 Others: Trends and Forecast (2019-2031)

5. Global Achalasia Treatment Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals: Trends and Forecast (2019-2031)
  • 5.4 Retail Pharmacy: Trends and Forecast (2019-2031)
  • 5.5 Online Pharmacy: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Achalasia Treatment Market by Region

7. North American Achalasia Treatment Market

  • 7.1 Overview
  • 7.2 North American Achalasia Treatment Market by Type
  • 7.3 North American Achalasia Treatment Market by Application
  • 7.4 United States Achalasia Treatment Market
  • 7.5 Mexican Achalasia Treatment Market
  • 7.6 Canadian Achalasia Treatment Market

8. European Achalasia Treatment Market

  • 8.1 Overview
  • 8.2 European Achalasia Treatment Market by Type
  • 8.3 European Achalasia Treatment Market by Application
  • 8.4 German Achalasia Treatment Market
  • 8.5 French Achalasia Treatment Market
  • 8.6 Spanish Achalasia Treatment Market
  • 8.7 Italian Achalasia Treatment Market
  • 8.8 United Kingdom Achalasia Treatment Market

9. APAC Achalasia Treatment Market

  • 9.1 Overview
  • 9.2 APAC Achalasia Treatment Market by Type
  • 9.3 APAC Achalasia Treatment Market by Application
  • 9.4 Japanese Achalasia Treatment Market
  • 9.5 Indian Achalasia Treatment Market
  • 9.6 Chinese Achalasia Treatment Market
  • 9.7 South Korean Achalasia Treatment Market
  • 9.8 Indonesian Achalasia Treatment Market

10. ROW Achalasia Treatment Market

  • 10.1 Overview
  • 10.2 ROW Achalasia Treatment Market by Type
  • 10.3 ROW Achalasia Treatment Market by Application
  • 10.4 Middle Eastern Achalasia Treatment Market
  • 10.5 South American Achalasia Treatment Market
  • 10.6 African Achalasia Treatment Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Achalasia Treatment Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Bausch Health
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Pfizer
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Accord HealthCare
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 AdvaCare Pharma
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Merz Therapeutics
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Galderma
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Zydus Pharmaceuticals
    • Company Overview
    • Achalasia Treatment Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Achalasia Treatment Market
  • Figure 2.1: Usage of Achalasia Treatment Market
  • Figure 2.2: Classification of the Global Achalasia Treatment Market
  • Figure 2.3: Supply Chain of the Global Achalasia Treatment Market
  • Figure 3.1: Driver and Challenges of the Achalasia Treatment Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Achalasia Treatment Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Achalasia Treatment Market ($B) by Type
  • Figure 4.3: Forecast for the Global Achalasia Treatment Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Calcium Channel Blockers in the Global Achalasia Treatment Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Nifedipine in the Global Achalasia Treatment Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Botulinum Toxin Injection in the Global Achalasia Treatment Market (2019-2031)
  • Figure 4.7: Trends and Forecast for Others in the Global Achalasia Treatment Market (2019-2031)
  • Figure 5.1: Global Achalasia Treatment Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Achalasia Treatment Market ($B) by Application
  • Figure 5.3: Forecast for the Global Achalasia Treatment Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Achalasia Treatment Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Retail Pharmacy in the Global Achalasia Treatment Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Online Pharmacy in the Global Achalasia Treatment Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Achalasia Treatment Market (2019-2031)
  • Figure 6.1: Trends of the Global Achalasia Treatment Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Achalasia Treatment Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Achalasia Treatment Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Achalasia Treatment Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Achalasia Treatment Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Achalasia Treatment Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Achalasia Treatment Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Achalasia Treatment Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Achalasia Treatment Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Achalasia Treatment Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Achalasia Treatment Market ($B) (2019-2031)
  • Figure 8.1: European Achalasia Treatment Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Achalasia Treatment Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Achalasia Treatment Market ($B) by Type (2025-2031)
  • Figure 8.4: European Achalasia Treatment Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Achalasia Treatment Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Achalasia Treatment Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Achalasia Treatment Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Achalasia Treatment Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Achalasia Treatment Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Achalasia Treatment Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Achalasia Treatment Market ($B) (2019-2031)
  • Figure 9.1: APAC Achalasia Treatment Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Achalasia Treatment Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Achalasia Treatment Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Achalasia Treatment Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Achalasia Treatment Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Achalasia Treatment Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Achalasia Treatment Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Achalasia Treatment Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Achalasia Treatment Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Achalasia Treatment Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Achalasia Treatment Market ($B) (2019-2031)
  • Figure 10.1: ROW Achalasia Treatment Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Achalasia Treatment Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Achalasia Treatment Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Achalasia Treatment Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Achalasia Treatment Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Achalasia Treatment Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Achalasia Treatment Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Achalasia Treatment Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Achalasia Treatment Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Achalasia Treatment Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Achalasia Treatment Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Achalasia Treatment Market by Type
  • Figure 12.2: Growth Opportunities for the Global Achalasia Treatment Market by Application
  • Figure 12.3: Growth Opportunities for the Global Achalasia Treatment Market by Region
  • Figure 12.4: Emerging Trends in the Global Achalasia Treatment Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Achalasia Treatment Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Achalasia Treatment Market by Region
  • Table 1.3: Global Achalasia Treatment Market Parameters and Attributes
  • Table 3.1: Trends of the Global Achalasia Treatment Market (2019-2024)
  • Table 3.2: Forecast for the Global Achalasia Treatment Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Achalasia Treatment Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Achalasia Treatment Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Achalasia Treatment Market (2025-2031)
  • Table 4.4: Trends of Calcium Channel Blockers in the Global Achalasia Treatment Market (2019-2024)
  • Table 4.5: Forecast for Calcium Channel Blockers in the Global Achalasia Treatment Market (2025-2031)
  • Table 4.6: Trends of Nifedipine in the Global Achalasia Treatment Market (2019-2024)
  • Table 4.7: Forecast for Nifedipine in the Global Achalasia Treatment Market (2025-2031)
  • Table 4.8: Trends of Botulinum Toxin Injection in the Global Achalasia Treatment Market (2019-2024)
  • Table 4.9: Forecast for Botulinum Toxin Injection in the Global Achalasia Treatment Market (2025-2031)
  • Table 4.10: Trends of Others in the Global Achalasia Treatment Market (2019-2024)
  • Table 4.11: Forecast for Others in the Global Achalasia Treatment Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Achalasia Treatment Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Achalasia Treatment Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Achalasia Treatment Market (2025-2031)
  • Table 5.4: Trends of Hospitals in the Global Achalasia Treatment Market (2019-2024)
  • Table 5.5: Forecast for Hospitals in the Global Achalasia Treatment Market (2025-2031)
  • Table 5.6: Trends of Retail Pharmacy in the Global Achalasia Treatment Market (2019-2024)
  • Table 5.7: Forecast for Retail Pharmacy in the Global Achalasia Treatment Market (2025-2031)
  • Table 5.8: Trends of Online Pharmacy in the Global Achalasia Treatment Market (2019-2024)
  • Table 5.9: Forecast for Online Pharmacy in the Global Achalasia Treatment Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Achalasia Treatment Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Achalasia Treatment Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Achalasia Treatment Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Achalasia Treatment Market (2025-2031)
  • Table 7.1: Trends of the North American Achalasia Treatment Market (2019-2024)
  • Table 7.2: Forecast for the North American Achalasia Treatment Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Achalasia Treatment Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Achalasia Treatment Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Achalasia Treatment Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Achalasia Treatment Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Achalasia Treatment Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Achalasia Treatment Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Achalasia Treatment Market (2019-2031)
  • Table 8.1: Trends of the European Achalasia Treatment Market (2019-2024)
  • Table 8.2: Forecast for the European Achalasia Treatment Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Achalasia Treatment Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Achalasia Treatment Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Achalasia Treatment Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Achalasia Treatment Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Achalasia Treatment Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Achalasia Treatment Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Achalasia Treatment Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Achalasia Treatment Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Achalasia Treatment Market (2019-2031)
  • Table 9.1: Trends of the APAC Achalasia Treatment Market (2019-2024)
  • Table 9.2: Forecast for the APAC Achalasia Treatment Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Achalasia Treatment Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Achalasia Treatment Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Achalasia Treatment Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Achalasia Treatment Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Achalasia Treatment Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Achalasia Treatment Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Achalasia Treatment Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Achalasia Treatment Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Achalasia Treatment Market (2019-2031)
  • Table 10.1: Trends of the ROW Achalasia Treatment Market (2019-2024)
  • Table 10.2: Forecast for the ROW Achalasia Treatment Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Achalasia Treatment Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Achalasia Treatment Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Achalasia Treatment Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Achalasia Treatment Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Achalasia Treatment Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Achalasia Treatment Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Achalasia Treatment Market (2019-2031)
  • Table 11.1: Product Mapping of Achalasia Treatment Suppliers Based on Segments
  • Table 11.2: Operational Integration of Achalasia Treatment Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Achalasia Treatment Revenue
  • Table 12.1: New Product Launches by Major Achalasia Treatment Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Achalasia Treatment Market